Revenue-based financing for D2C: when it actually works
Repayments that scale with sales sound gentler than a loan and cheaper than equity. Both are true in the right situation and expensively false in the wrong one.
- It is best suited to funding a known, repeatable return: inventory you will sell, or ad spend with a proven payback.
- The cost is a flat fee on the amount drawn, so paying back faster does not make it cheaper. That inverts loan intuition.
- Repayment moves with revenue, which protects cash in a bad month and takes more in a good one.
- It is the wrong instrument for anything speculative, because the repayment starts whether or not the bet works.
Revenue based financing has become a familiar option for Indian consumer brands. The pitch is appealing: money without dilution, repayment that flexes with your sales, and a decision in days rather than months.
It is a genuinely useful instrument. It is also frequently used for the wrong thing, and the reason is a small mechanical difference that changes everything about when it makes sense.
The mechanic that matters
A term loan charges interest over time. Borrow for three months instead of twelve and you pay considerably less. Speed saves money.
Revenue based financing typically charges a flat fee on the amount drawn. You owe that total regardless of how long repayment takes, collected as a percentage of monthly revenue until it clears. Repaying quickly does not reduce the cost, it only shortens the period.
That inverts the usual instinct. With a loan you want the shortest possible term. Here the term is a consequence, not a lever, and the only thing that determines whether the deal was good is what the money earned while you had it.
What it is genuinely good for
Two things, both characterised by high certainty and a short cycle.
The first is inventory you are confident of selling. A festive buy for lines with two years of history, where the constraint is that payment to the supplier lands months before revenue arrives. The return is knowable, the cycle is short, and the alternative is either equity or not buying enough stock.
The second is advertising spend with a proven payback period. If you know from real cohort data that a rupee spent on a specific channel returns within a defined window at a defined margin, funding that spend with capital that repays out of the resulting revenue is a clean match. The money and the return move together.
In both cases you are financing a known return, not buying an option on an unknown one.
Where it goes wrong
The failure mode is using it for anything speculative. A new product line, a new market, a rebrand, a category experiment.
The problem is not the cost. It is that repayment begins on schedule whether or not the bet works. A new line that takes three quarters to find its footing is being repaid out of revenue generated by your existing lines the whole time, which quietly starves the business that was working to fund the one that is not.
Equity exists precisely because some bets need patient money. Using a repayment instrument for a speculative purpose transfers risk onto your working capital at the worst possible moment.
Run the arithmetic on your own curve
Because the fee is flat and repayment is a share of revenue, the effective annualised cost depends entirely on how fast your revenue repays it. The same headline number is cheap for a fast moving brand and expensive for a slow one.
So convert every quote into an effective annual rate against your realistic revenue forecast, not the optimistic one. Then run the same exercise on a downside case where revenue comes in a third below plan, which stretches the repayment period and pushes the effective cost up.
If the downside case is uncomfortable, size the facility smaller rather than talking yourself into the upside.
The repayment comes off revenue, not profit
This is the detail that catches out thin margin brands. The percentage is applied to sales, before your platform commission, fulfilment, returns and marketing costs come out.
In a strong month that is comfortable. In a slow month, when your fixed costs are already spread across less revenue, a fixed share of top line disappearing can push contribution negative.
Model a bad month explicitly. If a soft period plus the repayment share leaves you unable to fund normal operations, the facility is too large regardless of how good the growth case looks.
How to decide
Ask what the money is buying and how certain the return is. If it funds a known, repeatable, short cycle return, this is often the cheapest capital available to a consumer brand and the dilution you avoid is real. If it funds a hope, use equity or use nothing, because a repayment schedule attached to an uncertain outcome is how a good brand ends up managing cash instead of building product.